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1. Introduction  
Stress-induced cardiomyopathy has achieved global notoriety in only 20 years since it was 
introduced as “Takotsubo cardiomyopathy” (which means “octopus trap” in Japanese) (Dote 
et al., 1991). It is also known as “left ventricular apical ballooning”, “ampulla cardiomyopathy” 
and “broken heart syndrome”. Stress-induced cardiomyopathy is associated with typical 
electrocardiographic findings and severe chest pain suggesting ST-segment elevation 
myocardial infarction (STEMI). However, emergency coronary angiography usually does not 
show significant stenosis or definite flow limitation. In general, left ventricular ejection fraction 
(LVEF) is markedly depressed and is recovered within the normal range within 1–2 weeks. 
Most cases have a good outcome and some may not even need further medical therapy if the 
underlying the cause is uncovered. Several hypotheses have been proposed but the 
pathophysiologic mechanism is incompletely understood. Here we discuss the clinical 
findings, diagnostic modalities, possible pathophysiologic mechanisms, prognosis and 
management of stress-induced cardiomyopathy. 
2. History of reporting of stress-induced cardiomyopathy 
In 1980, strong evidences implying stress-induced cardiomyopathy were reported via the 
autopsies of homicidal victims (Cebelin & Hirsch, 1980). They found pathognomonic findings of 
contraction band necrosis in 11 patients who had died due to a physical assault without internal 
injuries. One case report revealed that severe emotional stress could bring about deterioration of 
cardiac function which developed into pulmonary edema (Anon, 1986). Echocardiographic 
studies demonstrated that left ventricular wall motion abnormalities and myocardial damage 
could be accompanied by subarachnoid hemorrhage (Pollick et al., 1988). This pioneering work 
inspired other investigators, who discovered that LVEF and regional wall motion abnormalities 
were significant predictors of death in patients with subarachnoid hemorrhage (Sugimoto et al., 
2008). Reversible left ventricular dysfunction induced by excessive catecholamine surges in 
pheochromocytoma was also reported (Iga et al., 1989). This finding suggested that 
catecholamines at high concentrations can directly damage the myocardium. 
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Stress-induced cardiomyopathy was termed “Takotsubo cardiomyopathy” by Japanese 
cardiologists in 1991 (Dote et al., 1991). Advances in diagnostic imaging and emergency 
coronary angiography have contributed to increased recognition of stress-induced 
cardiomyopathy, and increasing numbers of reports have been published since then. 
3. Clinical observations: Single-center experiences 
We reported retrospective data of 39 patients diagnosed with stress-induced 
cardiomyopathy during 5 years in a single center (Lee, J.W. et al., 2010). Our results 
showed differences from other reports. In our study, 69% of patients were female, and the 
mean age was 61.3 ± 16.1 years. The most frequent symptom at initial presentation was 
dyspnea (46%) rather than chest pain (26%). Emotional stress was found in only 15% of 
subjects. The main triggering factors were physical stress associated with illness (59%), 
procedure-related complications (8%) and trauma (8%). Initial electrocardiography 
revealed T-wave inversion (46%), ST-segment elevation (28%) and ST-segment depression 
(5%). LVEF was recovered from 45 ± 16% upon hospital admission to 61 ± 13% upon 
hospital discharge. The level of B-type natriuretic peptide (BNP) was increased (745.4 ± 
905.6 pg/mL) and 23 patients (59%) had elevated levels of highly-sensitive C-reactive 
protein (hs-CRP; 44 ± 61 mg/L) at initial presentation. The peak level of creatine kinase-
MB (CK-MB) fraction and troponin I showed mild elevation (15.6 ± 20.9 ng/mL and 6.8 ± 
12.3 ng/mL, respectively) 
Echocardiography was shown to be a useful tool to detect transient left ventricular outflow 
tract (LVOT) obstruction, apical thrombus on the site of apical ballooning, and unusual 
inverted-type (mid-ventricular) ballooning. 
Three patients (8%) died due to pneumonia and 13 patients (33%) experienced cardiogenic 
shock. Inotropic agents were needed in 10 patients (26%) and 9 patients (23%) required 
mechanical ventilation. When we assessed the prognostic factors affecting adverse events 
such as death or shock, LVEF and hs-CRP levels were independent risk factors by 
multivariate logistic regression analyses (adjusted for age, sex, and other risk factors). 
4. Clinical findings 
In general, stress-induced cardiomyopathy is characterized by sudden chest pain or 
dyspnea, ST-segment elevation mimicking acute myocardial infarction (AMI) or deep T-
wave inversion, elevated levels of cardiac enzymes or BNP and transient left ventricular 
systolic dysfunction. Post-menopausal women seem to be more vulnerable to this 
syndrome. The definition is continually evolving. There are some divergences of opinion on 
clinical situations and management. 
4.1 Age and sex 
The elderly seem to be the most vulnerable to stress-induced cardiomyopathy. The mean 
age for presentation was >60 years (Bybee et al., 2004). However, a case of stress-induced 
cardiomyopathy in a newborn after fetal distress was caused by the umbilical cord being 
twisted around the chest and neck (Greco, 2011). The youngest patient we treated was a 26-
year-old female. Despite literature suggesting that the elderly are the most affected, recent 
case reports have shown the possibility of development of stress-induced cardiomyopathy 
in patients of any age.  
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The higher prevalence of females is a consistent finding in published series (Bybee et al., 
2004). Nevertheless, the reason for this difference in prevalence between males and females 
is unknown. Stöllberger & Finsterer suggested two intriguing hypotheses (Stöllberger & 
Finsterer, 2011). The first hypothesis is that males have been biologically better protected 
against the stress-induced cardiotoxicity of catecholamines than females throughout the 
centuries. They suggested that males were exposed to more physical stress and developed 
various protecting mechanisms (Stöllberger & Finsterer, 2011, as cited in Silventoinen et al., 
2001). The higher density of adrenergic receptors of cardiomyocytes in males may result in 
delayed saturation of receptors and improved protection against catecholamine storms 
(Stöllberger & Finsterer, 2011, as cited in Leibel et al., 1987). The second hypothesis is that 
males are biologically less resistant than females against the stress-induced cardiotoxicity of 
catecholamines. Males comprise 78.9% of sudden cardiac deaths (Fragkouli & 
Vouguiouklakis, 2010) and one of the risk factors for sudden unexplained death in epilepsy 
patients was being male (Monté et al., 2007). Large-scale cohort studies could provide 
answers for the age and sex predominance of stress-induced cardiomyopathy. 
4.2 Initial presenting symptoms 
The most common presenting symptoms of stress-induced cardiomyopathy are chest pain 
and dyspnea. Not all studies reported the initial symptoms (especially in the case of 
dyspnea). Nevertheless, chest pain was the cardinal symptom in 185 of 273 patients (67.8%) 
and dyspnea the second most common symptom in 40 of 225 patients (17.8%) (Gianni et al., 
2006). Cardiogenic shock, severe arrhythmia, mental change or syncope may be the initial 
presentation. Some patients suffer from chest pain and dyspnea; the most frequent symptom 
of stress-induced cardiomyopathy in patients in our institution was dyspnea. 
In our experience, patients with dyspnea had a longer stay in hospital, elevated levels of 
BNP and hs-CRP, and decreased initial LVEF, but these differences were not statistically 
significant (Lee, J.W. et al., 2011). A recent prospective study in a tertiary referral hospital 
demonstrated that chest pain was more frequently observed in the emotional stress group, 
whereas dyspnea was the presenting symptom in the physical stress group (acute illness 
and in-hospital surgery/procedure) (Lee, P.H. et al., 2010). 
New imaging modalities contribute to the early diagnosis of stress-induced 
cardiomyopathy. Hence, the proportion of initial symptoms might shift from emotional 
stress to physical stress.  
4.3 Triggering factors 
Triggering factors preceding this syndrome are, in general, divided into “emotional stress” 
and “physical stress”. A wide variety of emotional stressors have been reported, including 
panic, fear, anxiety, grief and anger (Prasad et al., 2008; Sharkey et al., 2010). These 
emotional stressors include immediate (“fight-or-flight”) responses and/or sustained 
responses, which implies the involvement of protective mechanisms of the body via the 
stress system (neurohormonal interaction) (Balkin & Cohen, 2011).  
Among physical stressors, pheochromocytoma, subarachnoid hemorrhage, exposure to 
catecholamine/beta-agonist drugs and procedure-related events are representative cases 
associated with catecholamine excess. Other physical stressors include hypoxia, infection, 
metabolic abnormalities, invasive procedures, and general anesthesia (Park et al., 2010; 
Prasad et al., 2008; Sharkey et al., 2010). Madhavan et al. suggested the importance of 
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physical stress (Madhavan et al., 2011). They suggested that patients with physical stressors 
had significant underlying co-morbidities that may contribute to the development of heart 
failure. In addition, physical stressors such as postoperative status may be associated with a 
more sustained surge in catecholamines compared with emotional stress, which may be 
shortlived (Park et al., 2010). 
4.4 Electrocardiographic findings 
The most common abnormality on electrocardiography (ECG) is ST-segment elevation 
resembling STEMI (Prasad et al., 2008). T-wave inversion is usually observed at initial 
presentation and during the subacute phase. The proportion of ST-segment elevation and T-
wave inversion was 208 of 255 patients (81.6%) and 160 of 249 patients (64.3%), respectively 
(Gianni et al., 2006). Q waves also could be detected in 63 of 198 patients (31.8%). T-wave 
inversion may resolve over 3–4 months but may occur as early as 4–6 weeks and, in some 
cases, be present beyond 1 year (Prasad et al., 2009, as cited in Kurisu et al., 2004 and 
Matsuoka et al., 2003).  
One study tried to distinguish stress-induced cardiomyopathy from anterior wall 
myocardial infarction by simple and non-invasive ECG tests (Jim et al., 2009). They found 
that if extensive left ventricular dysfunction and precordial ST-segment elevation were 
observed, the absence of ST-segment depression, or the presence of ST-segment elevation in 
inferior leads (particularly II ≥ III) were suggestive of stress-induced cardiomyopathy. Lead 
II is the most sensitive and specific for the detection of stress-induced cardiomyopathy 
because it is relatively protected from the opposing effect of lateral wall ischemia. 
4.5 Laboratory findings 
The level of troponin I or troponin T and CK-MB fraction is slightly elevated from baseline 
reference values. BNP levels in plasma are also elevated to various degrees (Lee, J.W. et al., 
2010 and Morel et al., 2009).  
One case-control study provided a comprehensive analysis of stress hormone and cardiac 
biomarker profiles in stress-induced cardiomyopathy, and the values were compared with 
those from patients with STEMI (Madhavan et al., 2009). The major findings were that: (1) 
levels of BNP were higher in stress-induced cardiomyopathy despite less necrosis of 
myocytes, similar left ventricular dysfunction and comparable hemodynamics; (2) there was 
a marked elevation in levels of an inflammatory biomarker (hs-CRP) in a magnitude similar 
to that seen in patients with STEMI. 
Inflammation may have a crucial role in stress-induced cardiomyopathy. Morel et al. 
demonstrated that inflammatory status was related to the initial impairment of LVEF and to 
the extent of neurohormonal activation (Morel et al., 2009). Other research teams 
demonstrated that patients who developed left ventricular apical ballooning due to severe 
physical stress in the Intensive Care Unit had a higher frequency of sepsis, cardiomegaly, 
pulmonary edema and hypotension (Park et al., 2005). 
One recent prospective study showed that inflammatory mediators and platelet-activity 
markers could be used to distinguish stress-induced cardiomyopathy from myocardial 
infarction (Pirzer et al., 2011). Expression of the platelet-activation marker CD62P and 
plasma levels of interleukin-6 were significantly lower in patients with stress-induced 
cardiomyopathy compared with myocardial infarction at the time of hospital admission. 
Plasma levels of interleukin-7 were significantly elevated in patients with stress-induced 
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cardiomyopathy compared with patients with myocardial infarction 2–4 days after hospital 
admission. 
The plasma concentrations of catecholamines during the acute phase were 2–3-times higher 
than in patients with AMI and heart failure, and 20-times higher than in normal adults 
(Wittstein et al., 2005). Uchida et al. also observed elevated levels of plasma epinephrine and 
norepinephrine in patients with stress-induced cardiomyopathy (Uchida et al., 2010). The 
plasma half-life of epinephrine is only 3 min (Zeb et al., 2011, as cited in Ferreira & Vane, 
1967), so measurement of catecholamines should be conducted at the time of symptom 
onset. 
4.6 Left ventricular systolic dysfunction 
Initial left ventricular systolic function is usually impaired upon hospital admission (mean 
LVEF, 20–49%) and, in general, resolves within days-to-weeks after initial presentation 
(mean period, 18 days) (Nef et al., 2010). Most patients achieve normal systolic function 
during hospitalization, but a few fail to reach the normal range (Sharkey et al., 2010). 
Moreover, a recent study revealed that absence of functional recovery within 1 week 
(ejection fraction <50%) was an independent factor associated with mortality (Lee, P.H. et 
al., 2010). 
4.7 Co-morbidity  
There are no reported associations between stress-induced cardiomyopathy and co-
morbidity. Collective data from 14 studies reported a history of hypertension in 43% of 
patients (108/247), diabetes mellitus in 11% (53/217) and current or past smoking in 23% 
(23/100). Others include chronic obstructive pulmonary disease, asthma and malignancy.  
One observational study showed that patients with stress-induced cardiomyopathy had 
significantly higher levels of high-density lipoprotein-cholesterol and lower levels of low-
density lipoprotein-cholesterol and triglyceride compared with age- and sex-matched 
patients with myocardial infarction (Gaddam et al., 2011). Hyper-alpha-lipoproteinemia was 
noted in 2 patients. That study had a major limitation because the study population was 
small. However, a history of dyslipidemia should be assessed at initial presentation. This 
result adds evidence that the pathogenesis is not due to atherosclerotic narrowing of 
epicardial coronary arteries. 
4.8 Preferred time of onset 
The occurrence of major cardiovascular events is not randomly distributed over time but 
instead exhibits chronobiological patterns. Stress-induced cardiomyopathy also seems to 
exhibit a temporal variation of onset, with peaks during the morning and in the summer 
(Bossone et al., 2011). One study reported that the highest number of cases was found on 
Monday and the lowest on Saturday. This phenomenon might be because of stress and 
catecholamine release (Manfredini et al., 2010). However, conclusions are hard to reach 
because of the relatively small number of patients involved in this study. 
5. Imaging modalities and implications 
Several imaging tools are used for the diagnosis of stress-induced cardiomyopathy: 
coronary angiography with left ventriculography, echocardiography, cardiac magnetic 
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resonance (CMR) and nuclear imaging. Each examination has its own diagnostic value and 
benefit. One should understand the advantages and disadvantages and select the most 
appropriate method for the purpose. 
5.1 Coronary angiography 
Coronary angiography is essential and the only way to rule out obstruction of coronary 
arteries (especially in cases of ST-segment elevation). The modified Mayo Clinic criteria to 
diagnose stress-induced cardiomyopathy demand the absence of obstructive coronary 
artery disease or angiographic evidence of acute rupture of plaques that could be 
responsible for the observed wall motion abnormalities. A recent report suggested the 
possible concurrence of coronary artery disease with stress-induced cardiomyopathy 
(Winchester et al., 2008). Hence, several cases might be excluded because of the presence of 
coronary artery disease. If coronary atherosclerotic changes are not significant and regional 
wall motional abnormalities extend beyond a single coronary artery, stress-induced 
cardiomyopathy should be suspected. The endocardial border can be readily detected by left 
ventriculography (Fig. 1). 
 
 
Fig. 1. Left ventriculography shows the typical pattern of apical ballooning with relative 
basal hypercontractility (A: end-diastole, B: end-systole) and inverted type of mid-
ventricular ballooning with apical sparing (C: end-diastole, D: end-systole). 
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5.2 Echocardiography 
Transthoracic echocardiography is the most important modality to distinguish this 
syndrome from AMI. It has many merits thanks to its non-invasiveness, portability, real-
time accessibility, reproducibility and concurrent monitoring of anatomic and physiologic 
abnormalities (Lee, J.W. et al., 2011). 
Echocardiography reveals the unique morphology of apical ballooning and the relative 
compensatory hypercontractiliy of the basal segments. One should closely observe two 
distinct features: (i) decrease in LVEF and (ii) (LVOT) obstruction. These factors are 
important to predict the severity and prognosis of stress-induced cardiomyopathy. 
The decreased LVEF seen at hospital admission is a significant independent risk factor for 
death or cardiogenic shock (Lee, J.W. et al., 2010). The absence of recovery in left ventricular 
dysfunction within 1 week is also a powerful independent factor associated with mortality 
(Lee, P. H. et al., 2010). 
Hypotensive events can be induced by dynamic LVOT obstruction, which results in the 
movement of the anterior mitral leaflets toward the interventricular septum in the systolic 
phase, so-called "systolic anterior motion” (SAM). Low cardiac output occurs as a result of 
reduced antegrade flow. This may occur in up to one-quarter of patients presenting with a 
septal bulge associated with SAM and mitral regurgitation (El Mahmoud et al., 2008). LVOT 
obstruction is a dynamic phenomenon depending on the hemodynamics at that time point, 
and thus echocardiography is a useful and readily accessible tool if unexplained 
hypotension or shock is observed. 
Acute mitral regurgitation can be found in stress-induced cardiomyopathy. Mitral 
regurgitation seems to develop mainly due to displacement of the papillary muscle, which 
leads to impaired leaflet coaptation secondary to tethering. Parodi et al. suggested that 
mitral regurgitation accompanied by severe left ventricular dysfunction was a potent 
predictor of hemodynamic derangement leading to hazardous manifestations, including 
pulmonary edema and cardiogenic shock (Parodi et al., 2007). 
Regional and global systolic function can be assessed and quantified by two-dimensional 
strain. This method is based on tracking the movement of stable acoustic patterns 
("speckles") within the myocardium frame-by-frame throughout the cardiac cycle. Despite 
the general perception of basal hypercontractility, total longitudinal strain showed that 
systolic function in basal segments was decreased in one study (Heggemann et al., 2009). 
Contrast echocardiography can be helpful in detection of the endocardial border 
(particularly if apical segments are difficult to evaluate because of poor image quality). 
Apical thrombus can be readily detected by contrast echocardiography. Contrast 
echocardiography can also demonstrate abnormalities in myocardial perfusion, which are 
indicative of microvascular dysfunction (Abdelmoneim, 2009). The normal myocardial 
perfusion pattern in the akinetic apex helps to discriminate stress-induced cardiomyopathy 
from anterior wall myocardial infarction. 
Real-time three-dimensional imaging techniques and transesophageal echocardiography can 
give better information on volumetric change and anatomic abnormalities 
5.3 CMR 
CMR provides information on wall-motion abnormalities as well as myocardial viability. 
Contrast-enhanced CMR can identify myocardial inflammation through the presence of 
edema by T2-weighted images and/or myocardial tissue injury by late gadolinium 
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enhancement (Schmalfuss, 2011). The special morphological pattern of late gadolinium 
uptake was reported recently for the first time (Avegliano et al., 2011). Early CMR (within 72 
h of hospital admission) demonstrated mild enhancement of signals in the segments with 
abnormal contractility, which was clearly different from the segments with no signal 
enhancement and normal contractility. This special morphological pattern corresponded to 
localized inflammation and edema in the affected area, which could be related to slower 
gadolinium washout determined by interstitial edema and inflammation (and perhaps very 
small areas of necrosis). This pattern becomes normal after recovery from myocardial edema 
and contractility. The morphological pattern suggests that the pathophysiology is related to 
diffuse damage of the myocardium and the microcirculation rather than involvement of 
coronary epicardial vessels. 
5.4 Nuclear imaging 
Single-photon emission computed tomography (SPECT) shows perfusion defects in the 
affected segment beyond single coronary distribution. Imaging also showed that the 
perfusion defect was slightly smaller in extent compared with the distribution of the wall-
motion defect in one study (Skovgaard et al., 2010). Fluorine 18 fluorodeoxyglucose positron 
emission tomography in the acute phase showed reduced (but not absent) glucose uptake in 
almost the entire left ventricle, indicating viable tissue. The myocardial glucose uptake 3 
months later was evenly distributed in the affected areas. 
The findings of 123I-meta-iodobenzylguanidine myocardial scintigraphy depicted a unique 
pattern of ventricular asynergy and suggested the existence of cardiac sympathetic 
hyperactivity (Akashi et al., 2004). Conversely, Skovgaard et al. could not find signs of 
cardiac sympathetic dysfunction as evidenced by a normal and unchanged washout rate 
(Skovgaard et al., 2010). However, they demonstrated the interesting finding of increased 
uptake in the lung, which was shown in chronic heart failure. 
The findings from these nuclear imaging studies provide possible evidence of coronary 
microvascular dysfunction. 
6. Mechanisms of stress-induced cardiomyopathy 
The mechanisms of stress-induced cardiomyopathy are incompletely understood. However, 
a growing body of evidence could explain the possible mechanism and pathophysiology. A 
proposed mechanism of stress-induced cardiomyopathy is summarized in Fig. 2.  
6.1 Brain–heart connection 
Although the heart has an intrinsic capacity to maintain homeostasis, it is always ready to 
recognize extrinsic stimuli through brain–heart connections and can elicit an appropriate 
response for physiological demands. This protective process is called the "stress system". 
The main central effectors of the stress system are highly interconnected and include 
hypothalamic corticotropin-releasing hormone and locus ceruleus-derived norepinephrine 
(Chrousos, 2009, as cited in Charmandari et al., 2005 and Chrousos & Gold, 1992). The 
principal peripheral effectors are glucocorticoids, which are regulated by the hypothalamic–
pituitary–adrenal axis, and the catecholamines norepinephrine and epinephrine, which are 
regulated by the systemic and adrenomedullary sympathetic nervous systems (Chrousos, 
2009). A functional positive feedback loop is formed by hypothalamic corticotrophin-
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releasing hormone and brainstem locus ceruleus-norepinephrine systems (Chrousos, 2007). 
The locus ceruleus also participates in a feedback loop with the adrenal medulla and the 
limbic system. The adrenal gland secretes epinephrine, which stimulates the locus ceruleus. 
Norepinephrine is released consecutively by this stimulus, which then sends signals to the 
hipppocampus and amygdala. The latter can re-stimulate the locus ceruleus in sequence 
(Soufer, 2002). 
 
 
Fig. 2. Proposed mechanism of stress-induced cardiomyopathy. NE, norepinephrine; Epi, 
epinephrine; AR, adrenoreceptor; NOS, nitric oxide synthase. 
Incessant emotional and/or physical stimuli may activate and sustain positive feedback 
stress response systems and result in marked elevation of plasma catecholamine levels in 
patients with stress-induced cardiomyopathy (Balkin & Cohen, 2011). 
6.2 Catecholamine excess 
Several situations that could induce sympathetic activation have suggested that cardiac 
dysfunction might be closely related to catecholamine excess. Subarachnoid hemorrhage 
and pheochromocytoma are typical examples (Kono et al., 1994; Pollick et al., 1988; Scott & 
Gutterman, 1995). Catecholamines could contribute to myocardial stunning in the absence 
of relevant myocardial perfusion abnormalities at rest (Morel et al., 2009). With respect to 
stress-induced cardiomyopathy, the possible contribution of catecholamines can be 
summarized into three components; (1) direct toxicity of norepinephrine/epinephrine and 
their metabolites; (2) adrenergic stimuli with spasm of the epicardial coronary artery and/or 
microvasculature; and (3) ß-adrenoreceptor-mediated stimulus-dependent G-protein 
stimulus trafficking. 
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6.2.1 Catecholamine toxicity 
Proof of direct catecholamine-induced cardiotoxicity has been known since the mid-1970s. 
Early investigations showed that intravenous injection catecholamines in rats could affect 
morphological change on the cardiomyocyte plasma membrane (the “sacolemma”) (Balkin 
& Cohen, 2011, as cited in Rona et al., 1975 & Boutet et al., 1976). When they injected 
catecholamines, the extracellular macromolecular tracer horseradish peroxidase became 
localized to intracellular compartments, which was retained in the extracellular 
environment in a normal physiological state.  
The synthetic catecholamine isoproterenol was shown to increase myocardial Ca2+ content 
and depress cardiac sarcolemmal ATP-dependent Ca2+ uptake, Ca2+-stimulated ATPase 
activity and Na+-dependent Ca2+ accumulation in experimental hearts (Tappia, 2001). Those 
authors also demonstrated that similar findings were seen in isolated rat hearts perfused 
with the catecholamine oxidation product adrenochrome, (10–25 μg/mL).  
These findings suggested that catecholamine and the oxidative stress that they cause result 
in the development of intracellular Ca2+ overload, heart dysfunction and subsequent 
myocardial death. 
6.2.2 Catecholamine and microvascular spasm 
The α1-adrenoreceptor is located in smooth muscle cells, which causes vasoconstriction in 
blood vessels (including the epicardial coronary artery). However, provocation tests using 
infusions of ergonovine or acetylcholine induced multivessel spasm in only 28% of patients 
with documented stress-induced cardiomyopathy (Gianni et al., 2006). This finding is 
insufficient to explain the underlying mechanism of stress-induced cardiomyopathy. 
Microvascular spasm by catecholamine-induced sympathetic stimulation can alter the 
oxygen delivery of the myocardium, which develops localized contractile dysfunction 
within seconds. If blood flow is restored before myocardial damage, cardiac function can 
recover. This phenomenon is termed “stunned” or “hibernating” myocardium (Heusch & 
Schulz, 1996). It may take days or weeks for such cardiac dysfunction to recover. 
As mentioned above, contrast echocardiographic perfusion imaging, CMR and nuclear 
imaging provide evidences of coronary microvascular dysfunction. Uchida et al. 
investigated the hypothesis that coronary microvessel apoptosis could be the missing link 
between stress and stress induced cardiomyopathy (Uchida et al., 2010). Plasma 
catecholamines, thrombolysis in myocardial infarction (TIMI) coronary flow grade and 
myocardial perfusion grade, and apoptosis of coronary microvessels in the biopsied 
myocardial specimens by terminal deoxynucleotidyl transferase-mediated nick end-labeling 
(TUNEL) were examined in 8 female patients with stress-induced cardiomyopathy. They 
found elevated levels of plasma epinephrine and norepinephrine, delayed myocardial 
perfusion without flow disturbance in the epicardial coronary arteries, focal myocardial 
necrosis, as well as extensive apoptosis of coronary microvessels in arterioles, venules and 
capillaries.  
Reactive hyperemia as a parameter of endothelial function and vascular response to acute 
mental stress could be measured by peripheral arterial tonometry. Women with a history of 
stress-induced cardiomyopathy demonstrated impaired endothelium-dependent 
vasodilation, excessive vasoconstriction, and augmented sympathetic activation after 
experiencing acute mental stress compared with age-matched post-menopausal controls and 
patients with myocardial infarction (Martin et al., 2010). 
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In summary, it can be hypothesized that catecholamine-induced apoptosis of endothelial 
cells of coronary microvessels and the subsequent microvessel spasm which results in 
myocardial stunning by oxidative stress due to the ischemia–reperfusion mechanism leads 
to stress induced cardiomyopathy (Uchida et al., 2010). 
6.2.3 ß-adrenoreceptor-mediated stimulus-dependent G-protein stimulus trafficking 
ß-adrenoreceptors are members of one of the largest families of cell-surface signaling 
proteins called G-protein-coupled receptors (GPCRs). The main function of GPCRs is to 
convert extracellular stimuli into intracellular signals (Rosenbaum et al., 2009). Cardiac 
tissue has two subtypes of ß-adrenoreceptor: ß1 and ß2. The ß1-adrenoreceptor stimulates 
only the G-αs protein. However, the ß2-adrenoreceptor can activate two G proteins, G-αs 
and G-αi (part of the Gs and Gi heterotrimers, respectively), which differentially regulate 
adenylate cyclase. The latter generates cyclic adenosine monophosphate (cAMP), which 
activates protein kinase A (PKA) (Rosenbaum et al., 2009).  
Specifically, in the heart, PKA phosphorylates the proteins involved in energy metabolism 
and excitation–contraction coupling. These include glycogen phosphorylase kinase, the L-
type calcium channel, the sarcoplasmic reticulum membrane protein phospholamban, and 
cytoskeletal proteins. These phosphorylation events result in enhanced cardiac contractility 
(inotropy), accelerated cardiac relaxation (lusitropy), and increased heart rate (chronotropy) 
(Balkin & Cohen, 2011, as cited in Xiao, 2001 & Bers, 2002). 
At physiological and elevated concentrations, norepinephrine, released from the 
sympathetic nerves, acts predominantly via the ß1-adrenoreceptor on ventricular 
cardiomyocytes, exerting positive inotropic and lusitropic responses. Epinephrine also binds 
the ß1-adrenoreceptor, but has a higher affinity for the ß2-adrenoreceptor. At physiological 
concentrations, epinephrine binding to the ß2-adrenoreceptor activates the Gs protein. At 
higher “supraphysiological” concentrations, epinephrine binds to the ß2-adrenoreceptor and 
switches signaling from the Gs protein to the Gi protein, a process called “stimulus 
trafficking”. This process results in negative inotropy, negative lusitropy and negative 
chronotropy. After the surge of epinephrine has finished, the ß2-adrenoreceptor coupled to 
Gi proteins switches back to Gs protein coupling or is internalized and degraded, enabling 
cardiomyocytes to recover their inotropic function (Lyon et al., 2008). 
6.3 Estrogen deficiency 
Studies have shown that post-menopausal women are susceptible to stress-induced 
cardiomyopathy (Bybee et al., 2004). This strong female predominance has been strongly 
associated with estrogen deficiency. Indeed, ovariectomised rats without estradiol 
supplementation exposed to immobilization stress had reduced left ventricular systolic function 
and increased heart rate and blood pressure in comparison with rats that were supplemented 
with estradiol (Ueyama et al., 2007). They also demonstrated that chronic supplementation with 
estrogen attenuated stress-induced sympatho–adrenal outflow from the brain to the heart 
(indirect action on the nervous system) and upregulated cardioprotective substances such as 
atrial natriuretic peptide and heat shock protein 70 in the heart (direct action on the heart). 
Estrogen has direct and indirect cardioprotective effects. The direct effect is rapid 
vasodilation primarily by activation of endothelial nitric oxide synthase (eNOS). The 
indirect long-term effect involves changes in the genetic expression of proteins that regulate 
vascular tone and the response to injury (Mendelsohn, 2002). 
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7. Prognosis and treatment 
In most cases, the prognosis of stress-induced cardiomyopathy is good. Reported overall in-
hospital mortality is 1.1% (Gianni et al., 2006), but the range varies to ~15–16% (Sharkey et 
al., 2010, and Lee, P.H. et al., 2010). The prevalence of complications was ~20%, including 
cardiogenic shock, acute heart failure, arrhythmias, intraventricular thrombus formation 
associated with distal embolization, left ventricular free wall rupture, recurrence, and even 
death (Bybee et al., 2004; Gianni et al., 2006; Zeb et al., 2010). 
Acute systolic heart failure is the most common complication of stress-induced 
cardiomyopathy, and occurs in ~45% of patients (Madhavan et al., 2011). Madhavan et al. 
developed and validated a risk score that can be calculated at the time of presentation. 
Scores of 1, 2, and 3 points were associated with a risk of acute heart failure of 28%, 58%, 
and 85%, respectively. No specific therapy is required but, if needed, diuretics are used to 
improve pulmonary edema. Combined α- & ß-blockers may be advantageous, but the 
usefulness of these agents in combination should be evaluated in the future. 
Cardiogenic shock may occur in the acute phase of stress-induced cardiomyopathy. Shock 
may be due to systolic dysfunction, or be secondary dynamic LVOT obstruction. Patients 
with systolic anterior motion or LVOT obstruction should not be exposed to inotropic agents 
even if there are in shock. Insertion of an intra-aortic balloon pump may be needed until the 
recovery of cardiac function is achieved. 
Right ventricular involvement is relatively common and associated with lower LVEF, a 
longer duration of hospitalization, more complications (e.g., severe congestive heart failure), 
the use of an intra-aortic balloon pump, and cardiopulmonary resuscitation (Elesber et al., 
2006). It has been reported that pleural effusion was more frequent in patients with stress-
induced cardiomyopathy and was predictive of right ventricular dysfunction (Haghi et al., 
2006). 
One should keep in mind the possibility of intraventricular thrombus formation, which can 
be found not only in the left ventricle but also in the right ventricle and left atrial appendage 
(Buchholz et al., 2010; Haghi et al., 2008; Sharkey et al., 2010). Apical thrombus in the left 
ventricle carries a great risk of cerebrovascular accident and distal embolization during the 
recovery phase. Short-term use of anticoagulants and heparin as well as close follow-up 
echocardiography can protect against additional embolic events. 
Arrhythmic complications include ventricular tachycardia, ventricular fibrillation, atrial 
fibrillation, atrioventricular block and sinus node dysfunction. The exact prevalence is 
unclear and no specific treatment has been developed. This issue needs more pooled data to 
assess the associations between stress-induced cardiomyopathy and arrhythmias (including 
conduction disorders).  
The true prevalence of recurrence is not known, but only 3.5–5% of patients experienced 
recurrence in two studies (Gianni et al., 2006, and Sharkey et al., 2010). 
Levosimendan has been suggested to be an ideal drug for patients with cardiogenic shock 
(Padayachee, 2007). Levosimendan is a non-catecholamine inotrope which sensitizes 
troponin C to calcium, leading to improved contractility. In addition, levosimendan does not 
compromise diastolic function. The opening of adenosine triphosphate-dependent 
potassium channels by levosimendan causes vasodilation. This decreases preload, afterload 
and pulmonary vascular resistance, and improves coronary perfusion. Further studies are 
required to determine the safety and efficacy of this agent before widespread use can be 
recommended. 
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8. Summary and conclusion 
The development of stress-induced cardiomyopathy involves multiple interactions. 
Emotional and/or physical stressors activate the stress system via positive feedback loops 
and catecholamines are produced. Excessive amounts of catecholamines directly affect 
cardiomyocytes, induce apoptosis of endothelial cells of coronary microvessels with 
subsequent microvessel spasm and ß-adrenoreceptor-mediated stimulus-dependent G-
protein stimulus trafficking. Estrogen deficiency makes the heart to vulnerable to stressors. 
Depending on the severity of cardiac involvement, various presentations can be seen. 
Diagnostic modalities should be chosen according to specific situations. Echocardiography 
is essential to monitor recovery or possible complications, and to plan further treatment. A 
growing body of evidence promises better understanding of stress-induced 
cardiomyopathy. 
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